The Europe diabetes devices market size is expected to
reach 8.7 billion by 2026, according to a new report by Grand View research,
Inc. registering a CAGR of 4.0% over the forecast period. The size of the
market is justified by the contribution from developed European economies such
as Germany, U.K., France, and Italy. The prevalence of diabetes is rising
amongst all ages in the European countries, mainly due to the unhealthy
lifestyle, obesity, overweight, and physical inactivity. According to the
International Diabetes Federation (IDF), around 66.0 million people in Europe
are suffering from diabetes and this number is expected to increase to around 81.0
million by 2045. Thus, rising diabetes population base in this region is
anticipated to be a major driver for the Europe diabetes devices market.
Additionally, the region is expected to witness
high growth rate during the forecast period due to the continuous efforts
towards diabetes control by the government and healthcare organizations such as
the IDF. These organizations provide required expertise and support diabetes
awareness campaigns through a network of stakeholders and partners. Also,
increasing health care funding in the region is anticipated to propel the
market’s growth.
Moreover, rising geriatric population is also
anticipated to propel the market growth over the forecast period. In 2018,
nearly one fifth of the Europe’s population was over 65 years age which is
further fueling the diabetes device market. According to the United Nation
report on World Population Aging, older population in Europe is projected to
constitute 35.0% of total population by 2050. Furthermore, leading manufacturers
are focusing on technological innovations and advanced product development to
gain remarkable share in the market.
Browse full research report on Europe
Diabetes Devices Market: https://www.grandviewresearch.com/industry-analysis/europe-diabetes-devices-market
Further key
findings from the report suggest:
- Germany held the largest market share owing to favorable
reimbursement policies, local presence of key market players, and
supportive government initiatives.
- In the self-monitoring and diagnostic devices segment, digital
glucose monitors held the largest market size of 1.2 billion in 2018 and
is growing at a CAGR of over 4.6% during the forecast period.
- Insulin pens held the largest market share in 2018 and the segment
is projected to grow at a CAGR of 3.7% over the forecast period. The
growth in this segment is attributed to ease of use and the ability to
deliver accurate dosage.
- Insulin pumps segment is expected to grow during the forecast
period. The segment is primarily driven by its advantage such as need of
fewer injections to deliver insulin.
- Some of the prominent players include in Europe diabetes devices
market are Eli Lilly and Company, Medtronic, Inc., Novo Nordisk A/S,
Sanofi, Becton, Dickinson and Company, F. Hoffmann-La Roche, Ltd., B.Braun
Melsungen AG, Ypsomed Holding AG, Abbott Laboratories and others.
Browse request sample of this report by
Grand View Research: https://www.grandviewresearch.com/industry-analysis/europe-diabetes-devices-market/request/rs1
Grand
View Research has segmented the Europe diabetes devices Market report on the
basis of product and region.
Europe Diabetes
Devices Product Outlook (Revenue, USD Million, 2015 - 2026)
- Monitoring and
diagnostic devices
- Digital glucose
monitors (DGM)
- Analog glucose
monitors (AGM)
- Continuous Glucose
Monitor (CGM)
- Insulin Delivery
Devices
- Pens
- Pumps
- Syringes
- Jet injectors
Europe Diabetes
Devices Regional Outlook (Revenue, USD Million, 2015 - 2026)
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Poland
- Switzerland
- Austria
About Grand View Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
No comments:
Post a Comment